Nasopharyngeal swab

Last updated

Nasopharyngeal swab
Diagnosis-image1.jpg
Nasopharyngeal swab
PurposeDiagnosis of certain viral infections
MedlinePlus 003747

A nasopharyngeal swab is a device used for collecting a sample of nasal secretions from the back of the nose and throat. [1] [2] The sample is then analyzed for the presence of organisms or other clinical markers for disease. This diagnostic method is commonly used in suspected cases of whooping cough, diphtheria, influenza, and various types of diseases caused by the coronavirus family of viruses, including SARS, MERS, and COVID-19. [3] [4] [5] [6] [7] [8]

Contents

Procedure

Video- Collecting a nasopharyngeal swab

To collect the sample, the swab is inserted in the nostril and gently moved forward into the nasopharynx, a region of the pharynx that covers the roof of the mouth. [9] The swab is then rotated for a specified period of time to collect secretions, then the swab is removed and placed into a sterile viral transport media, which preserves the sample for the subsequent analysis. [5] [6]

Material composition of swab

Similar in concept to the cotton swab, a swab used for nasopharyngeal collection constitutes a narrow stick made of a short plastic rod that is covered, at one tip, with adsorbing material such as cotton, polyester, or flocked nylon. (Some swab handles have been made of nichrome or stainless steel wire. [3] [10] ) The swab material used for a particular diagnostic application may vary based on the test type. Some research has shown that flocked swabs collect a larger volume of the sample material, when compared to fiber swabs. [7] [11]

Slightly different but related is nasopharyngeal aspiration. Rather than depending on a physical swab to catch material from the nasopharynx, aspiration uses a catheter that is attached to a syringe. As with the swab method, the catheter is placed into the nostril and gently advanced to the nasopharynx, where approximately one to three milliliters of saline are introduced, followed by immediate re-aspiration of the saline—along with cells and secretions—back into the syringe. [7] This aspiration method is often used when 1. the patient is an infant or elderly and 2. when the method is indicated as effective for a test type. [6] [12]

Diagrams

See also

Related Research Articles

<span class="mw-page-title-main">Virology</span> Study of viruses

Virology is the scientific study of biological viruses. It is a subfield of microbiology that focuses on their detection, structure, classification and evolution, their methods of infection and exploitation of host cells for reproduction, their interaction with host organism physiology and immunity, the diseases they cause, the techniques to isolate and culture them, and their use in research and therapy.

<span class="mw-page-title-main">Cough</span> Sudden expulsion of air from the lungs as a reflex to clear irritants

A cough is a sudden expulsion of air through the large breathing passages which can help clear them of fluids, irritants, foreign particles and microbes. As a protective reflex, coughing can be repetitive with the cough reflex following three phases: an inhalation, a forced exhalation against a closed glottis, and a violent release of air from the lungs following opening of the glottis, usually accompanied by a distinctive sound.

<span class="mw-page-title-main">Respiratory syncytial virus</span> Species of a virus

Respiratory syncytial virus (RSV), also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a common, contagious virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. Its name is derived from the large cells known as syncytia that form when infected cells fuse.

Bronchoalveolar lavage (BAL), also known as bronchoalveolar washing, is a diagnostic method of the lower respiratory system in which a bronchoscope is passed through the mouth or nose into an appropriate airway in the lungs, with a measured amount of fluid introduced and then collected for examination. This method is typically performed to diagnose pathogenic infections of the lower respiratory airways, though it also has been shown to have utility in diagnosing interstitial lung disease. Bronchoalveolar lavage can be a more sensitive method of detection than nasal swabs in respiratory molecular diagnostics, as has been the case with SARS-CoV-2 where bronchoalveolar lavage samples detect copies of viral RNA after negative nasal swab testing.

<i>Human coronavirus NL63</i> Species of virus

Human coronavirus NL63 (HCoV-NL63) is a species of coronavirus, specifically a Setracovirus from among the Alphacoronavirus genus. It was identified in late 2004 in patients in the Netherlands by Lia van der Hoek and Krzysztof Pyrc using a novel virus discovery method VIDISCA. Later on the discovery was confirmed by the researchers from the Rotterdam, the Netherlands The virus is an enveloped, positive-sense, single-stranded RNA virus which enters its host cell by binding to ACE2. Infection with the virus has been confirmed worldwide, and has an association with many common symptoms and diseases. Associated diseases include mild to moderate upper respiratory tract infections, severe lower respiratory tract infection, croup and bronchiolitis.

<span class="mw-page-title-main">Feline viral rhinotracheitis</span> Infectious disease of cats

Feline viral rhinotracheitis (FVR) is an upper respiratory or pulmonary infection of cats caused by Felid alphaherpesvirus 1 (FeHV-1), of the family Herpesviridae. It is also commonly referred to as feline influenza, feline coryza, and feline pneumonia but, as these terms describe other very distinct collections of respiratory symptoms, they are misnomers for the condition. Viral respiratory diseases in cats can be serious, especially in catteries and kennels. Causing one-half of the respiratory diseases in cats, FVR is the most important of these diseases and is found worldwide. The other important cause of feline respiratory disease is feline calicivirus.

Viral culture is a laboratory technique in which samples of a virus are placed to different cell lines which the virus being tested for its ability to infect. If the cells show changes, known as cytopathic effects, then the culture is positive.

<span class="mw-page-title-main">Nasopharyngeal carcinoma</span> Type of throat cancer; most common to occur in the nasopharynx

Nasopharyngeal carcinoma (NPC), or nasopharynx cancer, is the most common cancer originating in the nasopharynx, most commonly in the postero-lateral nasopharynx or pharyngeal recess, accounting for 50% of cases. NPC occurs in children and adults. NPC differs significantly from other cancers of the head and neck in its occurrence, causes, clinical behavior, and treatment. It is vastly more common in certain regions of East Asia and Africa than elsewhere, with viral, dietary and genetic factors implicated in its causation. It is most common in males. It is a squamous cell carcinoma of an undifferentiated type. Squamous epithelial cells are a flat type of cell found in the skin and the membranes that line some body cavities. Undifferentiated cells are cells that do not have their mature features or functions.

Equine viral arteritis (EVA) is a disease of horses caused by a virus of the species Alphaarterivirus equid, an RNA virus. It is the only species in the genus Alphaarterivirus, and that is the only genus in the Equarterivirinae subfamily. The virus which causes EVA was first isolated in 1953, but the disease has afflicted equine animals worldwide for centuries. It has been more common in some breeds of horses in the United States, but there is no breed "immunity". In the UK, it is a notifiable disease. There is no known human hazard.

In the diagnostic laboratory, virus infections can be confirmed by a myriad of methods. Diagnostic virology has changed rapidly due to the advent of molecular techniques and increased clinical sensitivity of serological assays.

<span class="mw-page-title-main">Influenza</span> Infectious disease, often just "the flu"

Influenza, commonly known as "the flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">Influenza-like illness</span> Medical diagnosis

Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, nausea, and sneezing typically in connection with a sudden onset of illness. In most cases, the symptoms are caused by cytokines released by immune system activation, and are thus relatively non-specific.

A rapid influenza diagnostic test (RIDT) tells whether a person has a current influenza infection by detecting the influenza viral nucleoprotein antigen. Commercially available RIDTs can provide results within 30 minutes. These results can be observed by a color change or other visual signals. For clinicians, RIDTs serve as a first-line test that can be confirmed by traditional diagnostic tests. RIDTs also allow clinicians to promptly start antiviral treatment in high-risk populations, to formulate effective infection control measures, and to make informed decisions regarding diagnostic investigations. RIDTs have been shown to reduce chest radiography and blood tests in ambulatory care settings, but not antibiotic prescribing, or time in the emergency department.

Candidatus Ornithobacterium hominis is a gram-negative bacterial species that colonises the human respiratory tract. Despite being related to the bird pathogen O. rhinotracheale, it is not a zoonosis. It has been detected in microbiome data from people around the world, including The Gambia, Madagascar and Central African Republic, Kenya, Mae La refugee camp in Thailand, rural Venezuela, Australia, and Fiji.

<span class="mw-page-title-main">COVID-19 testing</span> Diagnostic testing for SARS-CoV-2 virus infection

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.

Helen Y. Chu is an American immunologist who is an assistant professor of medicine at the University of Washington. Her research considers maternal immunization, with a focus on influenza and respiratory syncytial virus. During the COVID-19 pandemic, Chu was the first physician to recognise community transmission of the coronavirus disease within the United States.

<span class="mw-page-title-main">Seattle Coronavirus Assessment Network</span>

The Seattle Coronavirus Assessment Network (SCAN) is a public health surveillance program established in response to the COVID-19 pandemic. SCAN originated in March 2020 as a partnership between the Public Health department of Seattle and King County in Washington, USA and the Seattle Flu Study. SCAN's predecessor, the Seattle Flu Study, reported the first known case of community transmission of SARS-CoV-2 in the United States.

<span class="mw-page-title-main">Glossary of the COVID-19 pandemic</span> Glossary article for the COVID-19 pandemic

The COVID-19 pandemic has created and popularized many terms relating to disease and videoconferencing.

<span class="mw-page-title-main">Anne Wyllie</span> New Zealand microbiologist and epidemiologist

Anne Louise Wyllie is a New Zealand microbiologist who was the lead author of a 2020 research article which led to the development of the SalivaDirect PCR method of testing saliva for SARS-CoV-2, the virus that causes COVID-19. She has also worked on community studies to better understand pneumococcal disease. She is a research scientist in epidemiology with the Public Health Modeling Unit at Yale University.

References

  1. "Nasopharyngeal culture". MedlinePlus. 23 March 2020. Retrieved 25 March 2020.
  2. Pavord, T.; Pavord, M. (2004). The complete equine veterinary manual: A comprehensive and instant guide to equine health (2nd ed.). David & Charles. p. 206. ISBN   9780715318836.
  3. 1 2 Junkins, A. (2010). "20. Identification of Pathogenic Bacteria". In Mukherjee, K.I.; Ghosh, S. (eds.). Medical Laboratory Technology. Vol. 2 (2nd ed.). Tata McGraw-Hill. p. 515. ISBN   9781259000768.
  4. "Specimen Collection". Pertussis (Whooping Cough). Centers for Disease Control and Prevention. 18 November 2019. Retrieved 25 March 2020.
  5. 1 2 Irving, S.A.; Vandermause, M.F.; Shay, D.K.; Belongia, E.A. (2012). "Comparison of nasal and nasopharyngeal swabs for influenza detection in adults". Clinical Medicine & Research. 10 (4): 215–8. doi:10.3121/cmr.2012.1084. PMC   3494547 . PMID   22723469.
  6. 1 2 3 "Influenza Specimen Collection" (PDF). Centers for Disease Control and Prevention. n.d. Retrieved 25 March 2020. A nasopharyngeal (NP) swab is the optimal upper respiratory tract specimen collection method for influenza testing.
  7. 1 2 3 McPherson, R.A.; Pincus, M.R. (2017). Henry's Clinical Diagnosis and Management by Laboratory Methods (First South Asia ed.). Elsevier. p. 1083. ISBN   9788131231272.
  8. World Health Organization (19 March 2020). "Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: Interim guidance, 19 March 2020". WHO/COVID-19/laboratory/2020.5. World Health Organization. hdl:10665/331501 . Retrieved 25 March 2020.
  9. Marty FM, Chen K, Verrill KA (28 May 2020). "How to Obtain a Nasopharyngeal Swab Specimen". The New England Journal of Medicine. 382 (22): e76. doi: 10.1056/NEJMvcm2010260 . PMID   32302471.
  10. Gritzfeld, J.F.; Roberts, P.; Roche, L.; et al. (2011). "Comparison between nasopharyngeal swab and nasal wash, using culture and PCR, in the detection of potential respiratory pathogens". BMC Research Notes. 4. 122. doi: 10.1186/1756-0500-4-122 . PMC   3084159 . PMID   21489228.
  11. Sing, S.K., ed. (2014). Human Respiratory Viral Infections. CRC Press. p. 166. ISBN   9781466583207.
  12. Nunes, M.C.; Soofie, N.; Downs, S.; et al. (2016). "Comparing the Yield of Nasopharyngeal Swabs, Nasal Aspirates, and Induced Sputum for Detection of Bordetella pertussis in Hospitalized Infants". Clinical Infectious Diseases. 63 (Suppl. 4): S181–S186. doi:10.1093/cid/ciw521. PMC   5106614 . PMID   27838671.